Senti Biosciences, Inc. Common Stock
Symbol: SNTI (NASDAQ)
Company Description:
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
- Today's Open: $1.4
- Today's High: $1.435
- Today's Low: $1.325
- Today's Volume: 290.87K
- Yesterday Close: $1.39
- Yesterday High: $1.4099
- Yesterday Low: $1.36
- Yesterday Volume: 53.73K
- Last Min Volume: 16
- Last Min High: $1.375
- Last Min Low: $1.375
- Last Min VWAP: $1.375
- Name: Senti Biosciences, Inc. Common Stock
- Website: https://www.sentibio.com
- Listed Date: 2022-06-09
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001854270
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $36.36M
- Round Lot: 100
- Outstanding Shares: 26.16M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-02 | SCHEDULE 13D/A | View |
2025-08-07 | 10-Q | View |
2025-08-07 | 8-K | View |
2025-07-21 | 4 | View |
2025-07-21 | 3 | View |
2025-07-18 | 8-K | View |
2025-06-30 | 8-K | View |
2025-06-27 | 4 | View |
2025-06-27 | 4 | View |
2025-06-27 | 4 | View |
2025-06-27 | 4 | View |
2025-06-27 | 4 | View |
2025-06-27 | 4 | View |
2025-06-18 | 8-K | View |
2025-05-15 | SCHEDULE 13G/A | View |
2025-05-15 | SCHEDULE 13G/A | View |
2025-05-15 | SCHEDULE 13G/A | View |
2025-05-15 | SCHEDULE 13G/A | View |
2025-05-07 | SCHEDULE 13G/A | View |
2025-05-06 | 10-Q | View |